Protocol for the Treatment of Malignant Inoperable Bowel Obstruction: A Prospective Study of 80 Cases at Grenoble University Hospital Center

Journal of Pain and Symptom Management

Volumn 31, Issue 6, 2006, Pages 502-512

  Laval, Guillemette ^a   Arvieux, Catherine ^a   Stefani, Laetitia ^a   Villard, Marie Laure ^a   Mestrallet, Jean Phillippe ^a   Cardin, Nicolas ^a  

^a Departement de Cancerologie et d'Hematologie   (France)

Author keywords

antisecretory agents; hyoscine butylbromide; Malignant bowel obstruction; octreotide; palliative care; peritoneal carcinomatosis; venting gastrostomy

Indexed keywords

ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CARCINOMATOUS PERITONITIS; CLINICAL PROTOCOL; FEMALE; GASTROSTOMY; HUMAN; INOPERABLE CANCER; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; UNIVERSITY HOSPITAL; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CLINICAL PROTOCOLS; COHORT STUDIES; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 33746886253     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.10.009     Document Type: Article

References (31)

1. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 16 (2004) 3284-3292
2. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynaecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 360-365
3. Ripamonti C., Twycross R., Baines M., et al. Expert working group of the European Association for Palliative Care (EAPC). Clinical practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9 (2001) 223-233
4. Laval G., Girardier J., Lassaunière J.M., et al. The use of steroids in the management of inoperable intestinal obstruction in cancer patients: do they remove the obstruction?. Palliat Med 14 (2000) 3-10
5. Mangili G., Aletti G., Frigerio L., et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer 15 (2005) 830-835
6. Valverde A., and Mosnier H. Gastrostomie. Encyclopédie médico chirurgicale. Part III. Techniques chirurgicales (1998), Elsevier, Paris 40:280
7. French Agency for Sanitary Security of Health Products (AFSSAPS). Palliative care: specific use of usual medications except analgesics. AFSSAPS recommendations available from. www.afssaps.sante.fr
8. French Agency for Sanitary Security of Health Products (AFSSAPS). Palliative care: specific use of usual medications except analgesics. AFSSAPS recommendations available from. Med Pal 2 (2004) 72-90
9. Ripamonti C., and Mercadante S. How to use octreotide for malignant bowel obstruction. J Support Oncol 2 4 (2004) 357-364
10. Ripamonti C., Mercadante S., Groff L., et al. Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 19 (2000) 23-24
11. Fallon M.J. Physiology of somatostatin and his synthetic analog: octreotide. Eur J Palliat Care 1 1 (1994) 20-25
12. Copel L. The role of octreotide in palliative care. Oncologie 4 (2002) 419-422
13. Baines M., Olivier D.J., and Carter R.L. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet 2 (1985) 990-993
14. Fainsinger R.L., Spachynski K., Hanson J., and Bruera E. Symptom control in terminally ill patients with malignant bowel obstruction. J Pain Symptom Manage 9 (1994) 12-18
15. Baines M. The pathophysiology and management of malignant intestinal obstruction. In: Doyle D., Hanks G., and MacDonald N. (Eds). Oxford textbook of palliative medicine. 2nd ed. (1998), Oxford University Press, Oxford 526-533
16. ANAES (Agence Nationale d'Accréditation et d'Evaluation en Santé; www.anaes.fr) Modalités de prise en charge de l'adulte nécessitant des Soins Palliatifs -Décembre 02. Med Pal 2003;2:119-135.
17. FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer). Standards, Options, Recommandations (SOR) pour les traitements antalgiques médicamenteux des douleurs cancéreuses pour excès de nociception chez l'adulte, mise à jour du rapport original de 1996: Sept. 2002. Version abrégée:. www.fnlcc.com
18. FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer). Standards, Options, Recommandations (SOR) pour les traitements antalgiques médicamenteux des douleurs cancéreuses pour excès de nociception chez l'adulte, mise à jour du rapport original de 1996: Sept. 2002. Version abrégée:. Bull Cancer 89 12 (2002) 1067-1074
19. Hanks G., de Conno F., Cherny N., et al. Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer. Pain: the EAPC recommendations. Br J Cancer 84 5 (2001) 587-593
20. World Health Organization. Treatment of cancer pain. 2nd ed (1997), World Health Organization, Geneva 18-46
21. Loi N°2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé. JO N°54 du 5 mars 2002 (Law No. 2002-03 of March 2002 related to patient's rights and quality of health care system. JO No. 54 of 5 March 2002).
22. Brooksbank M.A., Game P.A., and Ashby M.A. Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med 16 6 (2002) 520-526
23. Beaufils D. Percutaneous endoscopic gastrostomy for terminally ill patients with intestinal obstruction. Med Pal 2 (2003) 211-213
24. Denis B., and Ollier J.C. Management of bowel obstruction in advanced abdominal or pelvic cancer. Gastroenterol Clin Biol 26 (2002) 372-385
25. Guirimand F. Management of bowel obstruction in patients with end-stage cancer. Med Pal 2 (2003) 197-210
26. Laval G., Arvieux C., Villard M.L., and Stefani L. L'occlusion intestinale terminale liée au cancer. La Revue du Praticien - Médecine Générale 2004 (Malignant Inoperable Bowel Obstruction. Practitian. Review-general medicine 18 640 (2004) 147-151
27. Jones M., Santanello S.A., and Falcone R.E. Percutaneous endoscopic versus surgical gastrostomy. J Parenter Enteral Nutr 14 (1990) 533-534
28. Mauro M.A., Koelher R.E., and Baron T.H. Advances in gastrointestinal intervention: the treatment of gastroduodenal and colorectal obstruction with metallic stents. Radiology 215 (2000) 659-669
29. Dalrymple J.L., Levenback C., Wolf J.K., et al. Trends among gynecologic oncology inpatient deaths: is end of life care improving?. Gynecol Oncol 85 (2002) 356-361
30. Schneider S., and Hébuterne X. Artificial nutrition in cancer patients. Nutr Clin Metab 15 (2001) 335-342
31. Laval G., Arvieux C., Villard M.-L., et al. Non-resectable malignant intestinal obstruction: 37 cases. Med Pal 3 (2004) 195-203